Suite 204 – 2389 Health Sciences Mall
Member Sector: Clinical Genetic Testing
Contextual Genomics was launched in 2012 to develop and deliver genomic-based molecular diagnostics to cancer patients. We are developing a suite of genomics based cancer tests to improve cancer prevention, treatment and monitoring. With deep expertise, multiple genomics-based cancer tests and strategic alliances with the world’s top pharmaceutical companies in place, we are leading this shift towards personalized cancer care.
Contextual Genomics’ team includes global leaders in research, clinical cancer genomics and commercialization. Achievements include articles in Nature and the New England Journal of Medicine, discovery of cancer genes, development of bioinfomatic tools, successful company creation, and a track record of improving human health using DNA.